drugset / Trial / NCT00373581
Effects of Vigabatrin on Cocaine Self-Administration
Phase 2
Terminated
1 enrolled
New York State Psychiatric Institute
Novel Cocaine Pharmacotherapies · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to determine if vigabatrin will decrease cocaine self-administration, cardiovascular effects, subjective effects and craving compared to placebo.
Timeline
- Start
- 2006-04
- Primary completion
- 2006-12
- Completion
- 2006-12
Outcome
Outcome not reported
Stopped (Business): “Funding ran out”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cocaine | Small molecule | 12 mg | Inhaled |
| Subject | Cocaine | Small molecule | 25 mg | Inhaled |
| Subject | Cocaine | Small molecule | 50 mg | Inhaled |
| Subject | Vigabatrin | Small molecule | 3 g | — |